Table 4.
Changes in plasma eicosapentaenoic acid levels in hypertriglyceridemic subjects after 8-weeks EPA supplementation stratified by GG and GC polymorphism of peroxisome proliferator-activated receptor alpha genotypes*

Changes in plasma eicosapentaenoic acid levels in hypertriglyceridemic subjects after 8-weeks EPA supplementation stratified by GG and GC polymorphism of peroxisome proliferator-activated receptor alpha genotypes*
